Alamar Biosciences, Inc.
ALMR
$20.75
$0.552.72%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 64.59M | 79.36M | |||
| Total Receivables | 19.52M | -- | |||
| Inventory | 39.93M | -- | |||
| Prepaid Expenses | 17.43M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 141.47M | -- | |||
|
|
|||||
| Total Current Assets | 141.47M | -- | |||
| Net Property, Plant & Equipment | 36.14M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | 1.84M | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 7.00M | -- | |||
| Total Assets | 186.45M | -- | |||
|
|
|||||
| Total Accounts Payable | 5.64M | -- | |||
| Total Accrued Expenses | 11.63M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 1.60M | -- | |||
| Total Finance Division Other Current Liabilities | 5.18M | -- | |||
| Total Other Current Liabilities | 5.18M | -- | |||
| Total Current Liabilities | 24.05M | -- | |||
|
|
|||||
| Total Current Liabilities | 24.05M | -- | |||
| Long-Term Debt | 74.97M | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 28.98M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 1.53M | -- | |||
| Total Liabilities | 129.53M | -- | |||
|
|
|||||
| Common Stock & APIC | 12.11M | -- | |||
| Retained Earnings | -190.10M | -- | |||
| Treasury Stock & Other | -80.00K | -- | |||
| Total Common Equity | -178.07M | -133.41M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 235.00M | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 235.00M | 235.00M | |||
|
|
|||||
| Total Common Equity | -178.07M | -133.41M | |||
| Total Preferred Equity | 235.00M | 235.00M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 56.93M | 101.59M | |||
|
|
|||||